|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net loss | |||||
| Adjustment to reconcile net loss to net cash used in operating activities | |||||
| Depreciation and amortization | |||||
| Share-based compensation | |||||
| Non-cash interest expense related to debt financing | |||||
| Accretion of notes payables | |||||
| Impairment on property plant and equipment and operating lease | |||||
| Loss on extinguishment of debt | |||||
| Fair Value Adjustment of Derivative Liabilities | |||||
| Change in fair value of warrant liabilities | |||||
| Inventory allowance | |||||
| Operating lease expense | |||||
| Deferred income taxes | |||||
| Changes in assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses | |||||
| Accounts payable and accrued expenses | |||||
| Operating lease liability | |||||
| Income taxes payable | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities | |||||
| Purchases of property, plant, and equipment | |||||
| Purchase of intangible assets | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from stock options exercised | |||||
| Proceeds from notes payable, derivative liabilities and factoring agreement | |||||
| Principal payments of notes payable and recourse factoring agreement | |||||
| Proceeds from equity financing, net | |||||
| Principal payments on finance lease | |||||
| Repayments of finance insurance premiums and software | |||||
| Refund of unused offering costs | |||||
| Payment of deferred offering costs | |||||
| Net cash (used in) provided by financing activities | |||||
| Net increase (decrease) in cash | |||||
| Cash, beginning of period | |||||
| Cash, end of period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Interest | |||||
| Income taxes | |||||
| Noncash investing and financing transactions: | |||||
| Modification on operating and finance leases | |||||
| Conversion of debt into equity | |||||
| Other long term asset additions included in accounts payable | |||||
| Shares issued for prepaid services | |||||
| Right-of-use assets obtained through operating lease | |||||
| Financing of property and equipment | |||||
| Financing of mask set and wafer | |||||
| Financing of insurance premiums and software | |||||
| Property and equipment financed through finance leases | |||||
| Termination of ROU Asset and Lease Liability | |||||
| Property and equipment additions included in accounts payable | |||||
| Reclassification of historical warrants | |||||
Loading...